Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay. by Gangal, S. G. et al.
Br. J. Cancer (1976) 33, 267
DEMONSTRATION OF CELLULAR IMMUNITY IN CHRONIC
MYELOID LEUKAEMIA USING LEUCOCYTE MIGRATION
INHIBITION ASSAY
S. G. GANGAL*, B. P. GOTHOSKARt, C. S. JOSHI* AND S. H. ADVANI$
From the *Biology Division and tBiophysics Division, Cancer Research Institute; tTata
Memorial Hospital, Tata Memorial Centre, Parel, Bombay 400012, India
Receivedl 20 October 1975 Accepted 27 November 1975
Summary.-Peripheral blood leucocytes from chronic myeloid leukaemia patients
in remission were tested for inhibition of migration in presence of solubilized mem-
brane antigens from leukaemic cells in 15 cases. Eight out of 9 autochthonous
combinations (88*8%) and 35/49 allogeneic combinations (7144%) showed inhibition
of migration. Antigens prepared from relapse leukaemic cell samples in 4 cases
showed inhibition of migration of autochthonous as well as allogeneic remission
leucocytes. The same batch of CML antigens inhibited migration of normal leuco-
cytes at the level of 22.2%. The difference between inhibition of migration shown
by remission leucocytes and normal leucocytes in presence of CML antigens was
statistically significant. Solubilized antigens, similarly prepared from normal
leucocytes, showed inhibition of migration of remission leucocytes to the extent
of 15% only. The difference between the reactivity of CML remission leucocytes
to normal and CML antigens was also statistically significant. No enhancement
of migration of remission leucocytes was seen with CML antigens.
THE PRESENCE of lymphocytes sensi-
tized to leukaemia-associated antigens
has often been demonstrated in patients
with acute leukaemia, using various tech-
niques to assess cellular immunity such
as lymphocyte blastogenesis, lymphocyte
mediated cytotoxicity and delayed cuta-
neous hypersensitivity (Freedman and
Kourilsky, 1969; Viza et al., 1969; Halter-
man and Leventhal, 1971; Rosenberg et
al., 1972; Santos et al., 1973; Anderson et
al., 1974; Oren and Herberman, 1971
and Leventhal et al., 1972). Attempts
have been made to boost leukaemia-
specific immunity (Powles et al., 1971
and Gutterman et al., 1973b), and to
correlate the presence and degree of
cellular immunity with the clinical stage
of the disease (Gutterman et al., 1972a,
1973c; Char et al., 1973).
Leukaemia-specific cellular immunity
in chronic myeloid leukaemic patients
(CML) has not, however, been reported
All correspondence to S. G. Gangal.
frequently. Oren and Herberman (1971)
showed that 30%0 of CML patients
specifically responded to low concentra-
tions of solubilized autochthonous leuk-
aemic cell membrane antigens in skin
tests.
In the present report attempts have
been made to study leukaemia-specific
reactivity in CML patients in remission
to solubilized autochthonous and allo-
geneic leukaemic cell membrane antigens
by leucocyte migration inhibition tests.
It was feasible to undertake these in-
vestigationsbecauseCMLoccursfrequently
in India.
MATERIALS AND METHODS
Antigens.-Leukaemic cells were collected
from the peripheral blood of 15 CML patients
when they were first admitted to the Tata
Memorial Hospital. They were diagnosed
as CML on the basis of clinical evidence and
bone marrow picture. They presented a
high WBC count in the peripheral blood,S. G. GANGAL, B. P. GOTHOSKAR, C. S. JOSHI AND S. H. ADVANI
ranging from 80,000 to 200,000. The bone
marrow picture showed hypercellularity with
granulocytes in all stages of differentiation
and the ratio of M: E varying from 10: 1
to 20: 1.
Ten ml of blood was withdrawn in 4 ml
of dextran-citrate mixture (6% Dextran,
mol. wt. 110,000 with equal volume of 5%
sodium citrate) from 15 CML patients. In
three cases, one subsequent relapse sample
each and in one case, two subsequent relapse
samples were also collected. The RBCs
were allowed to settle for 30 min at
room temperature. The supernatant WBCs
were washed three times and suspended in
10 ml saline. The cells were frozen and
thawed rapidly six times in normal saline,
with the help of dry ice. The lysis of cells
was checked microscopically. The cellular
extract was further subjected to membrane
extraction procedure using sodium chloride
solutions of graded molarity, as described
by Oren and Herberman (1971). Super-
natants from all the extracts were pooled,
clarified by centrifugation at 500 g for
10 min, and finally centrifuged at 105,000 g
for 60 min. The pellet obtained was sus-
pended in MEM and passed through millipore
filter (0-45 jtm). The protein was finally
adjusted to 50 ,ug/0-1 ml of MEM before
using for the experiment.
Leucocyte samples for testing.-Remission
leucocytes from 5 CML patients from
whom leukaemic cell antigens were prepared
(autochthonous combinations), as well as
from 14 other CML patients (allogeneic
combinations) were tested for inhibition of
migration. Remission patients were either
on maintenance therapy with busulfan (2 mg
twice a week), or free from any drug treat-
ment when tested. They were tested be-
tween 2 months to 2 years of remission
period. None of them had received any
blood transfusions. The peripheral WBC
count raniged from 8000 to 15,000 at the
time of testing. They were clinically and
haematologically free of the disease.
Leucocyte migration inhibition (LMI)
-The procedure utilized in these studies
was as described by Cochran et al. (1973b),
with slight modifications. Ten ml of peri-
pheral blood from CML patients in remission
and normal individuals was collected in
dextran-citrate mixture. In some cases
6% Dextran was added to heparinized
blood. RBCs were allowed to settle at
room temp. for 30 min. The leucocyte-
rich plasma was centrifuged. The leuco-
cytes were washed 3 times with saline
and finally suspended in MEM to contain
approximately 10 x 106 leucocytes per 0-1
ml. The cell viability was checked with
erythrocin B. Ten ,u of cell suspension was
drawn in 20 ,ul micropets, so as to allow
uniformity in cell number in every experi-
ment. The capillaries were sealed and centri-
fuged at 1500 rev/min. They were cut at
the cell-medium interface. Two capillaries
were fixed in each migration chamber (per-
spex round chamber with outer diameter of
2 cm and inner diameter of 1-6 cm, depth 2
mm and capacity 0-5 ml) with silicon grease.
The chamber was then filled with 0-5 ml of
medium containing MEM supplemented with
15% human AB group serum and antibiotics.
In test chambers, the medium contained
50 jug antigen. The chambers were closed
with coverslips and incubated at room
temperature for 18-24 h. After incubation,
the projected image of the migration field
was traced on paper and measured by plani-
metry. The migration indices were cal-
culated as described by Federlin et al. (1971).
Migration index (MI) =
area ofmigration in presence ofantigen
area of migration in absence of antigen
Migration indices ranging from 0-8 to 1-2
were considered as within normal range
(Federlin et al., 1971; Cochran et al., 1974),
while indices below 0-8 denoted inhibition
of migration and those above 1-2 indicated
enhancement effect. The statistical signi-
ficance of the reactions was assessed by
chi-square analysis using 2 x 2 contingency
tables. Yate's correction was applied.
Controls.-As controls, antigens extracted
from leukaemic leucocytes were tested for
inhibition of migration of leucocytes from
normal individuals. Similarly, 4 leuco-
cyte samples obtained from normal donors
were subjected to similar antigen extraction
procedures, and the solubilized membrane
antigens from normal leucocytes were tested
for inhibition of CML remission leucocytes
obtained from 5 patients.
RESULTS
In all, 20 antigen samples, includ-
ing 5 preparations from relapse blood, were
tested on 19 remission leucocyte samples.
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Each antigen was tested on 3-4 remission
leucocyte samples. The total number
of LMI tests performed with remission
leucocytes was 57. Each of the 15
leukaemic cell membrane antigens
prepared from untreated cases was
tested on 5 to 6 leucocyte samples
obtained from normal healthy persons.
The total number of LMI tests performed
with normal leucocytes was 81. Four
antigeneic preparations of normal leuco-
cytes were tested on 5 CML remission
leucocytes. The total number of LMI
tests performed was 20. In this group
of experiments a positive control with
leukaemic antigen was used to assess
the ability of remission leucocytes to
react.
Migration indices of all these tests
plotted on scattergram are shown in
Figs. 1 and 2. Each point represents the
mean of indices from 2 to 4 replicates.
Circled points represent autochthonous
reactions.
The LMI pattern of leucocytes from
CML patients in remission and normal
individuals in presence of leukaemic anti-
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gens is shown in Table I (Fig. 1). Forty-
three out of 57 (75.4%) tests performed
with remission leucocytes showed inhibi-
tion of migration. Eight of these tests
represented autochthonous combination.
TABLE I.-Migration Pattern ofLeucocytes
Obtained from CML Patients in Remis-
sion and Normal Healthy Individuals
in presence of Solubilized Leukaemic
Cell Membrane Antigens
Leucocyte
Migration pattern*
Enhance-
ment
Nil
5/81
(6 2%)
donors Inhibition Normal
CML remission 43/57t 14/57t
(75*4%) (24*6%)
Normal individuals 18/81 58/81
(22.2%) (71-6%)
* No. showing reactivity/No. tested.
t Eight of these represented autochthonous
reactions.
t One of these represented autochthonous
reaction.
The autochthonous reactions consisted of 2 tests
using original antigen prepared from leukaemic
cells from two untreated patients, 4 tests with
original and first relapse sample antigens from two
patients and 3 tests with original, first and second
relapse sample antigens from one patient.
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FIG. 1.-Scattergram of migration index (LMI) for leucocytes from CML patients in remission and
normal individuals in the presence of solubilized leukaemic cell membrane antigens.
Circled points: autochthonous reactions.
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FIG. 2.-Scattergram of LMI of leucocytes from CML patients in remission in the presence of solubilized leucocyte membrane antigens from CML patients and normal individuals.
Circled points: autochthonous reactions.
The percentage of autochthonous positive
LMI reactions was 88.8% and percentage
of allogeneic positive LMI reactions was
71-4%. In one autochthonous combina-
tion, the migration was within the normal
range. None of the tests showed enhance-
ment in migration of leucocytes (migra-
tion of leucocytes in presence of antigen
being more than migration of leucocytes
in absence of antigen). In contrast,
when normal leucocytes were allowed to
migrate in the presence of leukaemic cell
membrane antigen, only 18/81 (22-2%)
tests showed inhibition of migration,
while 58/81 (71.6%) tests showed migra-
tion within normal range. Enhancement
was shown in 5/81 (6.2%) tests. The
difference between inhibition pattern of
normal leucocytes and CML remission
leucocytes was statistically significant
(X2 36-43 at 1 d.f., P < 0-001). The
difference between enhancement of
migration shown by normal leucocytes
and remission leucocytes was not statis-
tically significant. However, it is thought
that enhancement of migration is a pheno-
menon of weak sensitization (Cochran
et al., 1974). The number of positive
reactions with normal leucocytes should
therefore be considered as 23/81. Even
then, the difference between positive
reactions using remission leucocytes and
normal leucocytes is highly significant
(x2
2 27X29 at 1 d.f., P < 0 001).
Eliminating 9 autochthonous reactions
from the total number of 57 tests
carried out with CML remission leuco
cytes (Table I), the difference be-
tween positive reactions using allogeneic
remission leucocytes and normal leuco-
cytes (inhibition + enhancement) is
still significant (x2 23X53 at 1 d.f.,
P < 0.005).
Table 2 and the scattergram in Fig. 2
show the comparison of migration pattern
of CML remission leucocytes in the
presence ofsolubilized membrane antigens
prepared from leukaemic cells and
normal Jeucocytes. Fifteen out of 20
tests performed with normal leucocyte
antigens showed migration of CML re-
mission leucocytes within the normal
range, while 2 showed enhancement and
3 showed inhibition of migration. The
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TABLE II. Migration Pattern of Leuco-
cytes Obtained from (ML patients in
Remission in Presence of Solubilized
Membrane Antigens of Leukaemic (Cells
and .Normal Leucocytes
Migration pattern*
Anitigeni Enihance-
donors Inihibition Normal meiit
CMIL leucocytes 43/57t 14/571 Nil
(75*40/) (24*60/)
Normal letcocytes :3/20 15/20 2/20
(15%) (75%) (10%)
* No. showinig reactivity/No. teste(l.
t Eight of these rep)resenited aitochthonotus
reactions.
OIne of these represente(l aoitochthoiiot)s
reactioll.
frequency of enhancement, again, was
not statistically significant. The differ-
ence between inhibition pattern with
leukaemic and normal antigens was sta-
tistically significant (X2 - 19 98 at 1 d.f.,
P < 0.005). Similarly the difference
between positive reaction (enlhancement
and inhibition together) with leukaemic
and normal antigens was significant
(X2 1391 at I d.f.,P < 0005).
DISCUSSION
Recently, leucocyte migration inhibi-
tion tests have been used to study tumour-
specific cellular immunity in a variety
of solidl tumours (Aindersoin et al., 1970;
Mavligit et al., 1972; Braun et al., 1972;
Cochran et al., 1973a, 1974; and Kjaer,
1974). Santos et al. (1973) reported the
in vitro production of MIF by remission
leucocytes of acute leukaemic patients,
which was tested indirectly on guinea-pig
macrophages. Gutterman (1973a) used
LMI test for studying cellular immunity
in a few cases of leukaemias which
included one CML in blast crisis.
The present report provides evidcence
for autochthonous, as well as allogeneic,
sensitization of CML patients in remission
to solubilize(d membrane antigens of
leukaemic cells. Theautochthonotus reac-
tivity was quite remarkable in that 8/9
tests showed inhibitioin of migrationi, ancd
is
most of them showed a very high degree
of inhibition (Fig. 1, circled points).
In four cases where antigens prepared
from relapse leukaemic cells were tested
on autochthonous remission le-ucocytes,
6/7 antigenic samples inhibited leucocyte
migration, indicating similarity or con-
stancy of leukaemic antigens during serial
relapses.
When leukaemic cell antigens were
tested on allogeneic CML remission leuco-
cytes, 35/49 (714%) tests showed inhibi-
tion of migration. It has been suggested
before that use of soluble antigens can
discriminate between tumour-specific and
HL-A reactivity (Gutterman et al., 1972b).
However, recently, Dean et al. (1975)
have reported positive blastogenesis of
normal lymphocytes using solubilized tu-
mour antigens. In our studies, the same
batch of leukaemia antigens did not
significantly inhibit the migration of
normal lcucocytes (22.2%). Similarly,
soluble antigens prepared from normal
leucocytes did not significantlv inhibit
migration of CML remission leucocytes
(15%) These results, and the reports
by Anderson et al. (1970) and Mavligit et
al. (1972) using solid tumours, suggest
that perhaps LMI is capable of dis-
tinguishing tumour-specificreactivityfrom
the HL-A reactivity.
While studying tumour-specific sensi-
tization with LMI test in breast canicer,
Cochran et al. (1974) have noted enhance-
ment of migration in a significant nutmber
of cases. This was suggested to be
indicative of weak sensitization. In the
present series of experiments enhlance-
ment to a siginificant level was not
obtained with any ofthe antigein-leucocyte
combination.
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